BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34287307)

  • 1. Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS Relapse.
    Ellis PM; Swaminath A; Pond GR
    Curr Oncol; 2021 Jul; 28(4):2778-2788. PubMed ID: 34287307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
    Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
    BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
    Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
    Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
    Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P
    J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.
    Zhou M; Wang Z; Yao Y; Zhou H; Liu M; Sun J
    Clin Transl Oncol; 2017 Jul; 19(7):865-873. PubMed ID: 28127669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
    Stinchcombe TE; Fan W; Schild SE; Vokes EE; Bogart J; Le QT; Thomas CR; Edelman MJ; Horn L; Komaki R; Cohen HJ; Kishor Ganti A; Pang H; Wang X
    Cancer; 2019 Feb; 125(3):382-390. PubMed ID: 30343497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of PET staging in limited-stage small-cell lung cancer.
    Xanthopoulos EP; Corradetti MN; Mitra N; Fernandes AT; Kim M; Grover S; Christodouleas JP; Evans TL; Stevenson JP; Langer CJ; Lee TT; Pryma DA; Lin LL; Simone CB; Apisarnthanarax S; Rengan R
    J Thorac Oncol; 2013 Jul; 8(7):899-905. PubMed ID: 23608814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer.
    Elegbede AA; Gibson AJ; Fu H; Dean ML; Ezeife DA; Lau H; Cheung WY; Bebb DG
    Am J Clin Oncol; 2020 Apr; 43(4):236-242. PubMed ID: 31842113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy.
    Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
    Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
    J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.
    Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J
    Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival following Multimodality Treatment Including Surgery for Stage IA-IIIB Small-Cell Lung Cancer.
    Weckler BC; Baldes N; Schirren J
    Thorac Cardiovasc Surg; 2019 Jun; 67(4):291-298. PubMed ID: 30092600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects.
    Demedts IK; Vermaelen KY; van Meerbeeck JP
    Eur Respir J; 2010 Jan; 35(1):202-15. PubMed ID: 20044461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic cranial irradiation in small cell lung cancer: A single institution experience.
    Nicholls L; Keir GJ; Murphy MA; Mai T; Lehman M
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):415-420. PubMed ID: 27453519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing outcomes of cancer care: lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 2000.
    Ellis PM; Delaney G; Della-Fiorentina S; Moylan E
    Australas Radiol; 2004 Sep; 48(3):364-70. PubMed ID: 15344988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy in small cell lung cancer: a national Italian survey.
    Ciammella P; Timon G; Bruni A; Franceschini D; Borghetti P; Giaj-Levra N; Greco C; Scotti V; Trovo M;
    Radiol Med; 2018 Jul; 123(7):554-560. PubMed ID: 29536412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of postoperative radiotherapy in multimodality treatment of resected small-cell lung cancer with lymph node metastasis.
    Liu WS; Zhao LJ; Wang S; Gong LL; Liu ZY; Yuan ZY; Wang P
    Eur J Surg Oncol; 2014 Sep; 40(9):1156-62. PubMed ID: 24655801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
    Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
    Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
    Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.